QiJiong Li
- Hepatology top 1%
- Pathology and Forensic Medicine top 5%
- Surgery top 10%
- Epidemiology top 10%
- Oncology top 10%
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (22 papers)Cancer Mechanisms and Therapy (13 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaHepatology
- Partner nations
- ChinaUnited States
In The Last Decade
QiJiong Li
32 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 74
- Hepatology 919
- Pathology and Forensic Medicine 463
- Surgery 382
- Epidemiology 302
- Oncology 297
Countries citing papers authored by QiJiong Li
This map shows the geographic impact of QiJiong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by QiJiong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites QiJiong Li more than expected).
Fields of papers citing papers by QiJiong Li
This network shows the impact of papers produced by QiJiong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by QiJiong Li. The network helps show where QiJiong Li may publish in the future.
Co-authorship network of co-authors of QiJiong Li
This figure shows the co-authorship network connecting the top 25 collaborators of QiJiong Li. A scholar is included among the top collaborators of QiJiong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with QiJiong Li. QiJiong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 9 | |
| 3 | 1 | |
| 4 | 8 | |
| 5 | 17 | |
| 6 | Lenvatinib, toripalimab plus hepatic arterial infusion chemotherapy in patients with high-risk advanced hepatocellular carcinoma: A biomolecular exploratory, phase II trialbreakdown → | 119 |
| 7 | 25 | |
| 8 | 14 | |
| 9 | 44 | |
| 10 | 1 | |
| 11 | 4 | |
| 12 | 23 | |
| 13 | 12 | |
| 14 | 39 | |
| 15 | 53 | |
| 16 | 9 | |
| 17 | 105 | |
| 18 | 17 | |
| 19 | 14 | |
| 20 | 25 |
About QiJiong Li
QiJiong Li is a scholar working on Hepatology, Pathology and Forensic Medicine and Epidemiology, having authored 33 papers that have together received 1.3k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (22 papers), Cancer Mechanisms and Therapy (13 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers). The work is most often cited by research in Hepatology (919 citations), Pathology and Forensic Medicine (463 citations) and Oncology (297 citations). QiJiong Li has collaborated with scholars based in China and United States. Frequent co-authors include Ming Shi, Minke He, Li Xu, Rong Guo, Wei Wei, Yong Le, Ruhai Zou, MinShan Chen, Zhongguo Zhou and ZhiCheng Lai. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.